Printer Friendly

Selling Science: Polio and the Promise of Gamma Globulin.

9780813574394

Selling Science: Polio and the Promise of Gamma Globulin

Stephen E. Mawdsley

Rutgers University Press

2016

210 pages

$54.95

Hardcover

Critical Issues in Health and Medicine

RA644

The author relates the story of the first large clinical trial to control polio using healthy children from an open population, when medical researcher William McD. Hammon and the National Foundation for Infantile Paralysis conducted an experiment in the early 1950s on about 55,000 healthy children in Texas, Utah, Iowa, and Nebraska, to assess the safety and effectiveness of gamma globulin to prevent paralytic polio. Despite its questionable results, the study was used to rationalize a federally sanctioned mass immunization study between 1953 and 1954. He considers how white and African American parents were persuaded to volunteer their healthy children for research, the indifference of researchers toward medical ethics, and the effects of marketing on medical research and the legacy of the gamma globulin clinical trials. ([umlaut] Ringgold, Inc., Portland, OR)

COPYRIGHT 2016 Ringgold, Inc.
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:ProtoView
Article Type:Book review
Date:Jul 1, 2016
Words:161
Previous Article:Facilities Design, 4th Edition (online access included).
Next Article:Geology for Ground Engineering Projects.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters